Benitec Biopharma (BNTC) Misses Q2 EPS by 264c
Tweet
Share
E-mailGet Alerts BNTC Hot Sheet
Join SI Premium – FREE
Benitec Biopharma (NASDAQ: BNTC) reported Q2 EPS of ($2.64).
For earnings history and earnings-related data on Benitec Biopharma (BNTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
